what do glp 1 and gip do Beyond the pancreas: contrasting cardiometabolic actions of GLP1 Frontiers | GLP-1/GIP dual agonist

W., Zhou, X

JSTOR 3371827

The first 2 weeks might bring dramatic relief followed by a period where progress seems to stall

The safety profile of cagrilintide-semaglutide was broadly consistent with that reported for other incretin-based therapies, although gastrointestinal adverse events and treatment discontinuations occurred more frequently than with either semaglutide or cagrilintide alone, highlighting the importance of careful patient selection and long-term adherence

Lu , khng dng gp i liu glutathion c khuyn co v c th lm tng nguy c gy hi cho c th

A: The goal is to help members achieve weight health GLP-1s have lasting physiological effects on the body, which needs to be taken into account when patients choose to stop taking these drugs